{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:53:04Z","timestamp":1774493584488,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1124\/jpet.105.098020","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T13:56:36Z","timestamp":1144331796000},"page":"132-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["A Selective p38\u03b1 Mitogen-Activated Protein Kinase Inhibitor Reverses Cartilage and Bone Destruction in Mice with Collagen-Induced Arthritis"],"prefix":"10.1016","volume":"318","author":[{"given":"Satyanarayana","family":"Medicherla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruban","family":"Mangadu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yebin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny J.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Almirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth G.","family":"Stebbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"O\u2019Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Kapoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Luedtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarvajit","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundeep","family":"Dugar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry K.","family":"Genant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A.","family":"Protter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.098020_bib1","doi-asserted-by":"crossref","unstructured":"Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL, and Griswold DE (1996) Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein\/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 279: 1453-1461.","DOI":"10.1016\/S0022-3565(25)21307-6"},{"key":"10.1124\/jpet.105.098020_bib2","doi-asserted-by":"crossref","unstructured":"Chan CC, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson AW, Forrest MJU, Gauthier JY, et al. (1999) Rofecoxib (Vioxx, MK-0966; 4(4-methylsulfonylphenyl)-3phenyl-2-(5 H)-furanone): a potent and orally active cyclooxygenase-2 inhibitor: pharmacological and biochemical profiles. J Pharmacol Exp Ther 290: 551-560.","DOI":"10.1016\/S0022-3565(24)34934-1"},{"key":"10.1124\/jpet.105.098020_bib3","doi-asserted-by":"crossref","unstructured":"Clerk A and Sugden PH (1998) The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases\/c-Jun N-terminal kinases (SAPKs\/JNKs). FEBS 426: 93-96.","DOI":"10.1016\/S0014-5793(98)00324-X"},{"key":"10.1124\/jpet.105.098020_bib4","doi-asserted-by":"crossref","unstructured":"Crnkic M, Mansson B, Larsson L, Geborek P, Heinergard D, and Saxne T (2003) Serum cartilage oligomeric matrix protein (COMP) decreased in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther 5: 181-185.","DOI":"10.1186\/ar760"},{"key":"10.1124\/jpet.105.098020_bib5","unstructured":"Desmoulins D, Ponteziere C, Agneray J, Ekindjian OG, and Cals MJ (1990) Effects of human recombinant IL-1 beta on rheumatoid and non-rheumatoid human synovial cell growth. Cell Mol Biol 36: 309-316."},{"key":"10.1124\/jpet.105.098020_bib6","doi-asserted-by":"crossref","unstructured":"Genant HK, Jiang Y, Peterfy C, Lu Y, Redei J, and Countryman P (1998) Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum 41: 1583-1590.","DOI":"10.1002\/1529-0131(199809)41:9<1583::AID-ART8>3.0.CO;2-H"},{"key":"10.1124\/jpet.105.098020_bib7","doi-asserted-by":"crossref","unstructured":"Goedert M, Cuenda A, Craxton M, Jakes R, and Cohen P (1997) Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO (Eur Mol Biol Organ) J 16: 3563-3571.","DOI":"10.1093\/emboj\/16.12.3563"},{"key":"10.1124\/jpet.105.098020_bib8","doi-asserted-by":"crossref","unstructured":"Goldring MB and Berenbaum F (1999) Human chondrocyte culture models for studying cyclooxygenase expression and prostaglandin regulation of collagen gene expression. Osteoarthritis Cartilage 7: 386-388.","DOI":"10.1053\/joca.1998.0219"},{"key":"10.1124\/jpet.105.098020_bib9","doi-asserted-by":"crossref","unstructured":"Hale KK, Trollinger D, Rihanek M, and Manthey CL (1999) Differential expression and activation of p38 mitogen-activated protein kinase \u03b1, \u03b2, \u03b3, and \u03b4 in inflammatory cell lineages. J Immunol 162: 4246-4252.","DOI":"10.4049\/jimmunol.162.7.4246"},{"key":"10.1124\/jpet.105.098020_bib10","doi-asserted-by":"crossref","unstructured":"Jiang Y, Zhao J, and Genant HK (2002) Macro and micro imaging of bone architecture, in Principles of Bone Biology (Bilezikian JP, Raisz LG, and Rodan GA eds) 2nd ed, pp 1599-1623, Academic Press, San Diego, CA.","DOI":"10.1016\/B978-012098652-1\/50195-5"},{"key":"10.1124\/jpet.105.098020_bib11","doi-asserted-by":"crossref","unstructured":"Jiang Y, Zhao J, Mitlak BH, Wang O, Genant HK, and Eriksen EF (2003) Recombinant human parathyroid hormone (1-34) [Teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18: 1932-1941.","DOI":"10.1359\/jbmr.2003.18.11.1932"},{"key":"10.1124\/jpet.105.098020_bib12","unstructured":"Jiang Y, Zhao J, White DL, and Genant HK (2000) Micro CT and micro MR imaging of 3D architecture of animal skeleton. J Musculoskel Neuron Interact 1: 45-51."},{"key":"10.1124\/jpet.105.098020_bib13","doi-asserted-by":"crossref","unstructured":"Joosten LA, Helsen MM, van de Loo FA, and van den Berg WB (1996) Anticytokine treatment of established type II collagen-induced arthritis in DBA\/1 mice: a comparative study using anti-TNF alpha, anti-IL-1 alpha\/beta and IL-1Ra. Arthritis Rheum 39: 797-809.","DOI":"10.1002\/art.1780390513"},{"key":"10.1124\/jpet.105.098020_bib14","doi-asserted-by":"crossref","unstructured":"Joosten LAB, Helsen MA, and Berg WB (1994) Accelerated onset of collagen-induced arthritis by remote inflammation. Clin Exp Immunol 97: 204-211.","DOI":"10.1111\/j.1365-2249.1994.tb06069.x"},{"key":"10.1124\/jpet.105.098020_bib15","doi-asserted-by":"crossref","unstructured":"Joosten LAB, Helsen MMA, Saxne T, Loo FAJ, Heinegard D, and Berg WB (1999a) IL-1\u03b1\u03b2 blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF alpha blockade only ameliorates joint inflammation. J Immunol 80: 5049-5055.","DOI":"10.4049\/jimmunol.163.9.5049"},{"key":"10.1124\/jpet.105.098020_bib16","doi-asserted-by":"crossref","unstructured":"Joosten LAB, Lubberts E, Helsen MMA, Saxne T, Roo CJJC, Heinegard D, and van den Berg WB (1999b) Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen induced arthritis. Arthritis Res 1: 81-91.","DOI":"10.1186\/ar14"},{"key":"10.1124\/jpet.105.098020_bib17","doi-asserted-by":"crossref","unstructured":"Joosten LAB, Lubberts E, Helsen MMA, and van den Berg WB (1997) Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol 159: 4094-4102.","DOI":"10.4049\/jimmunol.159.8.4094"},{"key":"10.1124\/jpet.105.098020_bib18","doi-asserted-by":"crossref","unstructured":"Kumar S, Boehm J, and Lee JC (2003) p38 MAP kinase: key signaling molecules as therapeutic target for inflammatory diseases. Nat Rev Drug Discov 9: 717-726.","DOI":"10.1038\/nrd1177"},{"key":"10.1124\/jpet.105.098020_bib19","doi-asserted-by":"crossref","unstructured":"Kumar S, McDonnell PC, Gum RJ, and Hand AT (1997) Novel homologues of CSBP\/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235: 533-538.","DOI":"10.1006\/bbrc.1997.6849"},{"key":"10.1124\/jpet.105.098020_bib20","doi-asserted-by":"crossref","unstructured":"Kumar S, Votta BJ, Rieman DJ, Badger AM, Gowen M, and Lee JC (2001) IL-1 and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. J Cell Physiol 187: 294-303.","DOI":"10.1002\/jcp.1082"},{"key":"10.1124\/jpet.105.098020_bib21","doi-asserted-by":"crossref","unstructured":"Larsson E, Mussener A, Heinegard D, Klareskog L, and Saxne T (1997) Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. Br J Rheumatol 36: 1258-1261.","DOI":"10.1093\/rheumatology\/36.12.1258"},{"key":"10.1124\/jpet.105.098020_bib22","doi-asserted-by":"crossref","unstructured":"Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T, Suda T, and Takashashi N (2002) p38 MAPK-mediated signals are required for inducing osteoclasts differentiation but not for osteoclast function. Endocrinology 143: 3105-3113.","DOI":"10.1210\/endo.143.8.8954"},{"key":"10.1124\/jpet.105.098020_bib23","doi-asserted-by":"crossref","unstructured":"Li X, Udagawa N, Takami M, Sato N, Kobayashi Y, and Takahashi N (2003) p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. Endocrinology 144: 4999-5005.","DOI":"10.1210\/en.2003-0166"},{"key":"10.1124\/jpet.105.098020_bib24","doi-asserted-by":"crossref","unstructured":"Li Z, Tran TT, Ma JY, O\u2019Young G, Kapoun AM, Chakravarty S, Dugar S, Schreiner G, and Protter AA (2004) p38 alpha mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats. J Cardiovasc Pharmacol 44: 486-492.","DOI":"10.1097\/01.fjc.0000141474.06383.6f"},{"key":"10.1124\/jpet.105.098020_bib25","doi-asserted-by":"crossref","unstructured":"McLay LM, Halley F, Souness JE, McKenna J, Benning V, Birrell M, Burton B, Belvisi M, Collis A, Constan A, et al. (2001) The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy. Bioorg Med Chem 9: 537-554.","DOI":"10.1016\/S0968-0896(00)00331-X"},{"key":"10.1124\/jpet.105.098020_bib26","doi-asserted-by":"crossref","unstructured":"Nieminen R, Leinonen S, Lahti A, Vuolteenaho K, Jalonen U, Kankaanranta H, Goldring MB, and Moilanen E (2005) Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytes. Mediators Inflamm 2005: 249-255.","DOI":"10.1155\/MI.2005.249"},{"key":"10.1124\/jpet.105.098020_bib27","doi-asserted-by":"crossref","unstructured":"Nishikawa M, Myoui A, Tomita T, Takashi K, Nampei A, and Yoshikawa H (2003) Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis Rheum 48: 2670-2681.","DOI":"10.1002\/art.11227"},{"key":"10.1124\/jpet.105.098020_bib28","doi-asserted-by":"crossref","unstructured":"Paleolog EM, Young S, Stark AC, McCloskey RV, Feldman M, and Maini RN (1998) Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 41: 1258-1265.","DOI":"10.1002\/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1"},{"key":"10.1124\/jpet.105.098020_bib29","doi-asserted-by":"crossref","unstructured":"Palmqvist P, Persson E, Conaway HH, and Lerner UH (2002) IL-6 leukemia inhibitory factor, and oncosatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kB ligand, osteoprotegerin and receptor activator of NF-kB in mouse calvariae. J Immunology 169: 3353-3362.","DOI":"10.4049\/jimmunol.169.6.3353"},{"key":"10.1124\/jpet.105.098020_bib30","unstructured":"Parfitt AM (1983) The stereologic basis of bone histomorphometry: theory of quantitative microscopy and reconstruction of the third dimension, in Bone Histomorphometry: Techniques and Interpretations (Recker R ed) pp 53-87, CRC Press, Inc., Boca Raton, FL."},{"key":"10.1124\/jpet.105.098020_bib31","doi-asserted-by":"crossref","unstructured":"Rioja I, Bush KA, Buckton JB, Dickson MC, and Life PF (2004) Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin Exp Immunol 137: 65-73.","DOI":"10.1111\/j.1365-2249.2004.02499.x"},{"key":"10.1124\/jpet.105.098020_bib32","doi-asserted-by":"crossref","unstructured":"Saxne T and Heinegard D (1992) Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheum 31: 583-591.","DOI":"10.1093\/rheumatology\/31.9.583"},{"key":"10.1124\/jpet.105.098020_bib33","doi-asserted-by":"crossref","unstructured":"Steeve KT, Marc P, Sandrine T, Dominique H, and Yannick F (2004) IL-5, RANKL, TNF-alpha\/Il-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15: 49-60.","DOI":"10.1016\/j.cytogfr.2003.10.005"},{"key":"10.1124\/jpet.105.098020_bib34","unstructured":"Suzuki Y, Nishikaku F, Nakatuka M, and Koga Y (1998) Osteoclast-like cells in murine collagen induced arthritis. J Rheumatology 25: 1154-1160."},{"key":"10.1124\/jpet.105.098020_bib35","doi-asserted-by":"crossref","unstructured":"Sweitzer SM, Medicherla S, Almirez R, Dugar S, Chakravarty S, Shumilla JA, Yeomans DC, and Protter AA (2004) Antinociceptive action of a p38alpha MAPK inhibitor, SD-282, in a diabetic neuropathy model. Pain 109: 409-419.","DOI":"10.1016\/j.pain.2004.02.016"},{"key":"10.1124\/jpet.105.098020_bib36","doi-asserted-by":"crossref","unstructured":"Takeshita S, Namba N, Zhao J, Jiang Y, Genant HK, Silva MJ, Brodt MD, Helgason CD, Kalesnikoff J, Rauh MJ, et al. (2002) SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat Med 8: 943-949.","DOI":"10.1038\/nm752"},{"key":"10.1124\/jpet.105.098020_bib37","doi-asserted-by":"crossref","unstructured":"Vingsbo-Lunderg C, Saxne H, Olsson H, and Holmdahl R (1998) Increased serum levels of cartilage oligomeric matrix protein chronic erosive arthritis in rats. Arthritis Rheum 41: 544-550.","DOI":"10.1002\/1529-0131(199803)41:3<544::AID-ART21>3.0.CO;2-#"},{"key":"10.1124\/jpet.105.098020_bib38","doi-asserted-by":"crossref","unstructured":"Williams RO, Feldmann M, and Maini RN (1992) Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 89: 9784-9788.","DOI":"10.1073\/pnas.89.20.9784"},{"key":"10.1124\/jpet.105.098020_bib39","doi-asserted-by":"crossref","unstructured":"Wooley PH, Dutcher HJ, Widmer MB, and Gilles S (1993) Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol 151: 6602-6607.","DOI":"10.4049\/jimmunol.151.11.6602"},{"key":"10.1124\/jpet.105.098020_bib40","doi-asserted-by":"crossref","unstructured":"Yamamoto A, Fukuda A, Seto H, Mivazaki T, Kadono Y, Sawada Y, Nakamura I, Katagiri H, Asano T, Tanaka Y, et al. (2003) Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts. Arthritis Rheum 48: 2682-2692.","DOI":"10.1002\/art.11214"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524327648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524327648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.098020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:55:01Z","timestamp":1740002101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524327648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0022356524327648"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.098020","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Selective p38\u03b1 Mitogen-Activated Protein Kinase Inhibitor Reverses Cartilage and Bone Destruction in Mice with Collagen-Induced Arthritis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.098020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}